New imaging agent could spot tumors more clearly

NCT ID NCT07258836

First seen Jan 06, 2026 · Last updated May 12, 2026 · Updated 17 times

Summary

This study tests a new injection called [18F]LY4214835 to see if it is safe and can help detect cancer in the body. About 41 healthy volunteers and people with cancer will receive the injection and be monitored for side effects and how the substance spreads. The goal is to improve imaging of tumors for better diagnosis.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • BAMF Health Inc.

    NOT_YET_RECRUITING

    Grand Rapids, Michigan, 49503, United States

  • Boston Medical Center

    NOT_YET_RECRUITING

    Boston, Massachusetts, 02118, United States

  • Ichor Research

    NOT_YET_RECRUITING

    Syracuse, New York, 13210, United States

  • Invicro

    RECRUITING

    New Haven, Connecticut, 06510, United States

  • Massachusetts General Hospital (MGH)

    NOT_YET_RECRUITING

    Charlestown, Massachusetts, 02129, United States

  • Memorial Sloan Kettering Cancer Center

    NOT_YET_RECRUITING

    New York, New York, 10065, United States

Conditions

Explore the condition pages connected to this study.